CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

The North America genetic testing services market is expected to reach US$ 4.98 billion by 2030; it is estimated to register ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

GeneDx Holdings (NASDAQ:WGS) stock is trading higher on Tuesday. The genetic testing company reported a third-quarter EPS ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit.

These findings demonstrate disparities in precise genetic diagnosis are not due to diagnostic yields ... GeneDx is at the ...

LifeLink DNA offers mobile and in-office DNA testing, drug testing, and fingerprinting, providing personalized and accessible ...

to provide genetic testing services, including hereditary cancer and pharmacogenetic testing, to veterans and their families. The company, known for its clinical molecular diagnostic testing ...